SCHEMBL3929329

SCHEMBL3929329

COC(=O)c1cc(Cl)c(OC(C)CC(=O)OC(C)(C)C)cc1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.37
GAA P10253 2/20 0.36
CA12 O43570 3/20 0.35
CA1 P00915 3/20 0.35
CA2 P00918 3/20 0.35
CA9 Q16790 3/20 0.35
CA7 P43166 2/20 0.34
CA14 Q9ULX7 2/20 0.34
PDK2 Q15119 1/20 0.34
PDK4 Q16654 1/20 0.34
LMNA P02545 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ATR Q13535 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3938177 0.88 HDAC3 (0.33) HTTCA12CA1CA2CA9
SCHEMBL3661787 0.78 HTT (0.46) HTTGAACA12CA1CA2
SCHEMBL3929327 0.74 GAA (0.40) HTTGAACA12CA1CA2
SCHEMBL2793251 0.72 GAA (0.58) HTTGAACA12CA1CA2
SCHEMBL7415528 0.69 CA12 (0.55) HTTGAACA12CA1CA2
SCHEMBL3661788 0.68 GAA (0.43) GAACA12CA1CA2CA9
SCHEMBL30463099 0.67 CA12 (0.53) GAACA12CA1CA2CA9
SCHEMBL2726967 0.67 CA12 (0.53) GAACA12CA1CA2CA9
SCHEMBL21662627 0.67 MAPT (0.43) HTTGAACA12CA1CA2
SCHEMBL1109633 0.67 CA12 (0.65) HTTGAACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069355-A1 NOVEL TRICYCLIC SPIROPIPERIDINE COMPOUNDS, THEIR SYNTHESIS AND THEIR USES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY AstraZeneca AB (SE) 2009-06-17 EP disclosed
WO-2009011654-A1 PROCESS FOR THE PREPARATION OF CYCLIC SPIROPIPERIDINES ASTRAZENECA AB (SE) 2009-01-22 WO disclosed
WO-2009011655-A1 SPLROPIPERIDINE COMPOUNDS, A PROCESS OF THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THE TREATMENT OF AIRWAY DISEASES, INFLAMMATORY DISEASES, COPD OR ASTHMA ASTRAZENECA AB (SE) 2009-01-22 WO disclosed
WO-2008010765-A1 NOVEL TRICYCLIC SPIROPIPERIDINE COMPOUNDS, THEIR SYNTHESIS AND THEIR USES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY ASTRAZENECA AB (SE) 2008-01-24 WO disclosed